Trial Profile
Clinical study of Hematide in chronic renal failure patients not on dialysis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Feb 2022
Price :
$35
*
At a glance
- Drugs Peginesatide (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Takeda
- 02 Jun 2016 New trial record